Literature DB >> 4354138

Urinary corticosteriod and diphenylhydantoin metabolite patterns in neonates exposed to anticonvulsant drugs in utero.

J W Reynolds, B L Mirkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4354138     DOI： 10.1002/cpt1973145891

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.

Authors:  P M Loughnan; A Greenwald; W W Purton; J V Aranda; G Watters; A H Neims
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 3.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

4.  Development of endogenous glucocorticoids, mineralocorticoids and progestins in the human fetal and perinatal period. Influence of antenatal treatment with betamethasone or phenobarbital.

Authors:  W G Sippell; F Bidlingmaier; D Knorr
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

5.  Kinetics of placentally transferred phenytoin and its p-hydroxylated metabolites in newborn infants.

Authors:  A Rane; C Hoppel; B Höjer
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

Review 6.  Clincial pharmacokinetics in neonates.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.